Antidepressant monotherapy in pre-bipolar depression; predictive value and inherent risk

被引:44
|
作者
O'Donovan, Claire [1 ,2 ]
Garnham, Julie S. [1 ]
Hajek, Tomas [1 ,2 ]
Alda, Martin [1 ,2 ]
机构
[1] Queen Elizabeth 2 Hlth Sci Ctr, Mood Disorders Program, Dept Psychiat, Halifax, NS B3H 2E2, Canada
[2] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada
关键词
bipolar depression; unipolar depression; depressive mixed state; mixed symptoms; antidepressant medication;
D O I
10.1016/j.jad.2007.08.003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To identify specific treatment-emergent symptoms in response to antidepressant therapy in depression preceding bipolar disorder. Methods: Retrospective chart review of response to antidepressants in "pre-bipolar" depression, compared to a matched unipolar sample. Results: Family history of completed suicide (p=0.0003) and bipolar disorder (p=0.004) were more common in the pre-bipolar subgroup. Earlier age of onset of diagnosed depression (p=0.005) as well as even earlier episodes of untreated retrospectively diagnosed major depression (p<0.0001) were associated with a future bipolar course. The pre-bipolar group was less likely to respond to antidepressant treatment (p=0.009). Treatment-emergent "mixed" symptoms (two or more symptoms of DSM IV mania, mood lability, irritability/rage with co-existing depression) and in particular, "serious symptoms" (treatment emergent or increased agitation, rage or suicidality) occurred more commonly in the bipolar group. The two variables that best accounted for the between-group differences in logistic regression, were early age at first symptoms of depression and treatment-emergent agitation. Conclusions: Family history of completed suicide and/or bipolar disorder, early onset of depressive symptoms as well as treatment-emergent "mixed" symptoms are common in depression preceding the diagnosis of bipolar disorder. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:293 / 298
页数:6
相关论文
共 41 条
  • [21] Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar ll depression: A randomized, double-blind, parallel-group, prospective study
    Amsterdam, Jay D.
    Lorenzo-Luaces, Lorenzo
    Soeller, Irene
    Li, Susan Qing
    Mao, Jun J.
    DeRubeis, Robert J.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2015, 185 : 31 - 37
  • [22] Predictive Value of Early Improvement in Bipolar Depression Trials: A Post-hoc Pooled Analysis of Two 8-week Aripiprazole Studies
    Kemp, D. E.
    Calabrese, J. R.
    Eudicone, J. M.
    Ganocy, S.
    Tran, Q. V.
    McQuade, R. D.
    Marcus, R. N.
    Vester-Blokland, E.
    Owen, R.
    Carlson, B. X.
    [J]. PSYCHOPHARMACOLOGY BULLETIN, 2010, 43 (02) : 5 - 27
  • [23] Gender differences in post-stroke depression: A longitudinal analysis of prevalence, persistence and predictive value of known risk factors
    Volz, Matthias
    Ladwig, Simon
    Werheid, Katja
    [J]. NEUROPSYCHOLOGICAL REHABILITATION, 2021, 31 (01) : 1 - 17
  • [24] Predictive value of cervical cytokine, antimicrobial and microflora levels for pre-term birth in high-risk women
    Manning, Rashmi
    James, Catherine P.
    Smith, Marie C.
    Innes, Barbara A.
    Stamp, Elaine
    Peebles, Donald
    Bajaj-Elliott, Mona
    Klein, Nigel
    Bulmer, Judith N.
    Robson, Stephen C.
    Lash, Gendie E.
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1) : 11246
  • [25] Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine Tumors
    Alexander V. Fisher
    Alexandra G. Lopez-Aguiar
    Victoria R. Rendell
    Courtney Pokrzywa
    Flavio G. Rocha
    Zaheer S. Kanji
    George A. Poultsides
    Eleftherios A. Makris
    Mary E. Dillhoff
    Eliza W. Beal
    Ryan C. Fields
    Roheena Z. Panni
    Kamran Idrees
    Paula Marincola Smith
    Clifford S. Cho
    Megan V. Beems
    Shishir K. Maithel
    Emily R. Winslow
    Daniel E. Abbott
    Sharon M. Weber
    [J]. Journal of Gastrointestinal Surgery, 2019, 23 : 651 - 658
  • [26] Predictive Value of Chromogranin A and a Pre-Operative Risk Score to Predict Recurrence After Resection of Pancreatic Neuroendocrine Tumors
    Fisher, Alexander V.
    Lopez-Aguiar, Alexandra G.
    Rendell, Victoria R.
    Pokrzywa, Courtney
    Rocha, Flavio G.
    Kanji, Zaheer S.
    Poultsides, George A.
    Makris, Eleftherios A.
    Dillhoff, Mary E.
    Beal, Eliza W.
    Fields, Ryan C.
    Panni, Roheena Z.
    Idrees, Kamran
    Smith, Paula Marincola
    Cho, Clifford S.
    Beems, Megan V.
    Maithel, Shishir K.
    Winslow, Emily R.
    Abbott, Daniel E.
    Weber, Sharon M.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2019, 23 (04) : 651 - 658
  • [27] Predictive value of cervical cytokine, antimicrobial and microflora levels for pre-term birth in high-risk women
    Rashmi Manning
    Catherine P. James
    Marie C. Smith
    Barbara A. Innes
    Elaine Stamp
    Donald Peebles
    Mona Bajaj-Elliott
    Nigel Klein
    Judith N. Bulmer
    Stephen C. Robson
    Gendie E. Lash
    [J]. Scientific Reports, 9
  • [28] Incremental predictive value of screening for anxiety and depression beyond current type 2 diabetes risk models: a prospective cohort study
    Atlantis, Evan
    Pour, Shima Ghassem
    Girosi, Federico
    [J]. BMJ OPEN, 2018, 8 (01):
  • [29] PREDICTIVE VALUE OF EMOTIONAL EATING, DEPRESSION AND ANXIETY FOR WEIGHT GAIN POST-LAPROSCOPIC GASTRECTOMY Psychology and bariatric surgery - pre and post-op challenges
    Yang, Y.
    Loi, K.
    Suh, H.
    Magdy, M.
    Mcnamara, L.
    Dong, L.
    Karantanis, W.
    Jia, S.
    [J]. OBESITY SURGERY, 2019, 29 : 994 - 994
  • [30] Effects of Fish Oil Monotherapy on Depression and Prefrontal Neurochemistry in Adolescents at High Risk for Bipolar I Disorder: A 12-Week Placebo-Controlled Proton Magnetic Resonance Spectroscopy Trial
    McNamara, Robert K.
    Strawn, Jeffrey R.
    Tallman, Max J.
    Welge, Jeffrey A.
    Patino, L. Rodrigo
    Blom, Thomas J.
    DelBello, Melissa P.
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2020, 30 (05) : 293 - 305